Answers are grounded in this paper and cite their sources.
Case-fatality rates in Ebola treatment centers (ETCs) varied widely during the Ebola virus disease (EVD) outbreak in West Africa.We assessed the influence of referral pathway on ETC case-fatality rates with a retrospective cohort of 126 patients treated at the Mathaska ETC in Port Loko, Sierra Leone.The patients consisted of persons who had confirmed EVD when transferred to the ETC or who had been diagnosed onsite.The case-fatality rate for transferred patients was 46% versus 67% for patients diagnosed onsite (p = 0.02).The difference was mediated by Ebola viral load at diagnosis, suggesting a survival selection bias.Comparisons of case-fatality rates across ETCs and clinical management strategies should account for potential survival selection bias.A s of February 14, 2016, the 2014-2016 outbreak of Ebola virus in West Africa had resulted in >14,000 cases of Ebola virus disease (EVD) and ≈4,000 deaths in Sierra Leone (1).The country's strategy for managing the outbreak and isolating patients included decentralized Ebola treatment centers (ETCs) and Ebola isolation centers (EICs), which were also known as community care centers and holding centers (2,3).EICs were transitional facilities meant for admission and isolation of patients who were awaiting results of Ebola diagnostic testing (real-time PCR) and provision of basic care (e.g., administration of oral rehydration solution) (2).EIC patients with Ebola virus-negative test results were discharged, and those with positive results were transferred to an ETC.In contrast to EICs, ETCs could care for patients suspected of having and those confirmed to have EVD without transfer of patients between facilities.EICs were initially designed to address a shortfall in ETC bed capacity, although their use continued even as ETC bed capacity increased during the outbreak (1).Recent studies on EVD clinical outcomes (2,4-7) demonstrate considerable variability in case-fatality rates (37%-74%) and call for further analyses to understand the reason(s) for this variability.Predictors of higher case-fatality rate after ETC admission are age (4-6,8) and higher viremia at diagnosis (9,10) and, less consistently, longer symptom duration before admission (4-6,8,9); clinical presentation with confusion, diarrhea, and conjunctivitis (4-6,8); and biochemical evidence of kidney injury, hepatitis, or both (5).One study reported early EVD-associated deaths (i.e., in the community) with a case-fatality rate of 24% before ETC transfer (9).None of these studies examined the care pathway of EVD patients or the extent to which direct admission to an ETC versus transfer from an EIC influenced case-fatality rates measured in ETCs.We sought to investigate whether referral pathway had any influence on case-fatality rate.We specifically sought to determine whether there was a statistically significant difference in case-fatality rate between EVD patients admitted directly to the ETC compared with patients first admitted to an EIC and subsequently transferred to the ETC after confirmation of EVD status.
No takes yet. Share an insight, caveat, or question.
Rudolf et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: